The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis

被引：0
|
作者：
Xiao Wang
Xuan He
Pei Zhang
Mengdie Zhang
Rui Ma
Rouli Dai
Xin Li
机构：
[1] Nanjing Medical University,School of Health Policy and Management
[2] Wuxi No.2 People’s Hospital,Department of Science and Technology
[3] Wuxi Xinwu District Center for Health Promotion and Education,School of Pharmacy
[4] Nanjing Medical University,Center for Global Health, School of Public Health
[5] National Institute of Drug Clinical Trials,undefined
[6] the Fourth Affiliated Hospital of Nanjing Medical University,undefined
[7] Nanjing Medical University,undefined
来源：
International Journal for Equity in Health | / 22卷
关键词：
National volume-based procurement policy; Interrupted time series; Drug use; Alternative drugs; Centralized procurement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis
    Wang, Xiao
    He, Xuan
    Zhang, Pei
    Zhang, Mengdie
    Ma, Rui
    Dai, Rouli
    Li, Xin
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2023, 22 (01)
  • [2] The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018–2019: an interrupted time-series analysis
    Ying Yang
    Lei Chen
    Xinfeng Ke
    Zongfu Mao
    Bo Zheng
    BMC Health Services Research, 21
  • [3] The impacts of Chinese drug volume-based procurement policy on the use of policy-related antibiotic drugs in Shenzhen, 2018-2019: an interrupted time-series analysis
    Yang, Ying
    Chen, Lei
    Ke, Xinfeng
    Mao, Zongfu
    Zheng, Bo
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [4] Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
    Wang, Ni
    Yang, Ying
    Xu, Luxinyi
    Mao, Zongfu
    Cui, Dan
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [5] Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
    Ni Wang
    Ying Yang
    Luxinyi Xu
    Zongfu Mao
    Dan Cui
    BMC Public Health, 21
  • [6] IMPACTS OF NATIONAL VOLUME-BASED PROCUREMENT POLICY ON PRICES OF NON-WINNING DRUGS IN CHINA: AN INTERRUPTED TIME SERIES
    Fu, M.
    Feng, L.
    Peng, J.
    Ma, Y.
    Zhao, M.
    Fang, Y.
    Lin, Y.
    Wu, Y.
    Jiang, M.
    VALUE IN HEALTH, 2024, 27 (12) : S319 - S319
  • [7] Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls
    Chen, Yilin
    Ji, Xu
    Xiao, Hong
    Unger, Joseph M.
    Cai, Yi
    Mao, Zongfu
    Yeung, Kai
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] The impact of National Centralised Drug Procurement policy on the use of policy-related original and generic drugs in China
    Yang, Ying
    Hu, Runhu
    Geng, Xin
    Mao, Lining
    Wen, Xiaotong
    Wang, Zhaolun
    Hao, Siyu
    Cui, Dan
    Mao, Zongfu
    INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2022, 37 (03): : 1650 - 1662
  • [9] Impact of national volume-based procurement policy on drugs treating chronic Myelogenous Leukemia
    Zhao Yang
    Yiran Li
    Siyu Liu
    Xiao Han
    Yongyi Wu
    Xiaohan Fan
    Yuan Li
    Bin Jiang
    Journal of Health, Population and Nutrition, 44 (1)
  • [10] Impact of '4+7' volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China
    Wang, Jing
    Yang, Ying
    Xu, Luxinyi
    Shen, Yuan
    Wen, Xiaotong
    Mao, Lining
    Wang, Quan
    Cui, Dan
    Mao, Zongfu
    BMJ OPEN, 2022, 12 (03):
12345